Price target
3.000.000.00%
The 1 analyst offering 1 year price forecasts for RNAZ have a max estimate of — and a min estimate of —.
Analyst rating
Based on 1 analyst giving stock ratings to RNAZ in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
RNAZ EPS for the last quarter is −0.74 USD despite the estimation of −0.58 USD. In the next quarter EPS is expected to reach −0.49 USD. Track more of TransCode Therapeutics, Inc. financials and stay on top of what is up with the company.
In the next quarter TransCode Therapeutics, Inc. revenue is expected to reach 300.00 K USD. Check out TransCode Therapeutics, Inc. revenue and earnings and make informed decisions.
According to analysts, RNAZ price target is 3.00 USD with a max estimate of 3.00 USD and a min estimate of 3.00 USD. Check if this forecast comes true in a year, meanwhile watch TransCode Therapeutics, Inc. stock price chart and keep track of the current situation with RNAZ news and stock market news.